In addition to the acquisition, Quest Diagnostics and the Cleveland Clinic have embarked on a strategic collaboration that will evaluate biomarkers for various diseases, with Quest developing tests for some of them.
Biomarker testing firm Cleveland HeartLab is still growing fast, and it doesn’t plan on slowing down anytime soon. The three-year-old startup has just tacked an additional $14.7 million in fresh capital onto the $18.4 million series B round it raised last summer. This time the investment was led by local Cleveland VC firm Mutual Capital […]
Dickon Waterfield discusses why Lantern's navigation works.
Cardiac inflammation biomarker test company Cleveland HeartLab has been tapped as the Ohio Venture Association‘s “venture of the year.” The last year has been an eventful one for the Cleveland-based company: It spurned a buyout offer from an unidentified Massachusetts suitor, closed an $18.4 million series B round of investment, moved into a new building […]
Biomarker test company Cleveland HeartLab made a splash recently at TEDMED, with about 500 conference-goers taking the company’s heart inflammation tests. Results of the TEDMED tests showed that 41 percent of those who submitted samples had high cholesterol or low HDL (good cholesterol), 28 percent showed evidence of hardening of the arteries and 12 percent […]
After making major inroads among community-based physicians, cardiac inflammation biomarker test company Cleveland HeartLab is looking to expand its business into the health and wellness market. The Cleveland-based clinical reference laboratory, which provides cardiovascular testing for thousands of U.S. physicians, is now aiming to partner with wellness companies and self-insured employers to diversify its customer […]
Landing angel investment involves a little bit more than calling up a bunch of rich guys and hoping for the best. Obtaining that initial investment is often a huge hurdle for startups, but once the cash comes in, it provides a critical source of early funding — lifeblood for young, hungry companies. And as the […]
Richard Fu details the company's approach to nutrition therapy and strategy for patients using GLP-1s.
Fresh off an $18 million fundraise, biomarker testing company Cleveland HeartLab plans today to sign a lease for 27,000 square feet of new office space. HeartLab CEO Jake Orville told MedCity News in July about the company’s intention to lease new space in Cleveland’s growing Health-Tech Corridor between downtown and University Circle. Now, those plans […]
Biomarker test-maker Cleveland HeartLab has closed an $18.4 million series B round of funding, which was led by two Boston-area investors. The size of the round is a testament to the explosive growth that the young company has achieved in less than two years of existence after being spun out from Cleveland Clinic — and […]
Cleveland HeartLab, which makes a biomarker-based heart test, has rebuffed an acquisition offer and instead taken an Ohio tax credit to keep growing the company, according to Ohio government officials. The company received a six-year tax credit from the state of Ohio that’s valued at nearly $423,000. State officials claimed that without the tax credit, […]
Cleveland is already well-known for its high quality medical care. But its reputation is growing elsewhere. Some of the nation’s best and brightest are flocking to University Circle to be on the cutting edge of the biotech innovation. Channel 3’s Maureen Kyle continues our “Brain Gain” series with a look at how this could be […]
How Apella leverages technology to increase OR efficiency.
In the words of Cleveland HeartLab CEO Jake Orville, business has "exploded" since the beginning of the year, just months after his company launched a proprietary test for cardiac inflammation under a fee-for-service model. Cleveland HeartLab is a CLIA-certified and CAP-accredited reference lab that does an array of lipid and inflammation tests for clients, including CardioMPO, a proprietary test for cardiac inflammation marker myeloperoxidase.
Tommy G. Thompson, former secretary of the U.S. Department of Health and Human Services-turned-healthcare consultant, will headline Cleveland HeartLab‘s first annual symposium on cardiovascular disease. The symposium Where Inflammation Meets Lipids (pdf) has attracted more than a dozen thought-leaders who will speak on a range of cardiovascular disease prevention, diagnosis and management topics. The symposium […]
Cleveland HeartLab LLC has added a test of low-density lipoprotein, the so-called “bad cholesterol,” to its portfolio of heart-inflammation tests. The company’s NMR LipoProfile test measures and counts LDL particles, which carry cholesterol in the blood and can build up on artery walls, leading to atherosclerosis and cardiovascular disease.The higher the LDL particle level, the […]
Updated 4:29 p.m., March 18, 2010 The cardiac inflammation biomarker developed by Dr. Stanley Hazen and his colleagues at the Cleveland Clinic was a valuable and proven technology, thought Jake Orville, president and chief executive of Cleveland HeartLab. The question: How to take a test for the biomarker to market? Based on Hazen’s research, Cleveland […]
Updated 4:24 p.m. Cleveland Clinic spinoff Cleveland HeartLab has completed a $3 million fundraising round, and named its executives and advisers. Investors in the round included Glengary LLC, Second Generation Ltd. and Zapis Capital Group LLC, all in Northeast Ohio, according to a company release. Cleveland HeartLab is a clinical reference laboratory specializing in next-generation […]